Items where Author is "Pfeifer, Heike"

Article

Pfeifer, Heike and Goekbuget, Nicola and Voelp, Christian and Huettmann, Andreas and Luebbert, Michael and Stuhlmann, Reingard and Dengler, Julanta and Kreuzer, Karl-Anton and Beck, Joachim and Stelljes, Matthias and Schmid, Mathias and Wassmann, B. and Leimer, Lothar and Spiekermann, Karsten and Terwey, Theis E. and Schaefer-Eckart, K. and Ditz, D. and Lindemann, H. and Morgner, A. and Schaich, Markus and Burmeister, Thomas and Binckebanck, A. and Hoelzer, Dieter and Ottmann, Oliver G. (2010) Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL). BLOOD, 116 (21): 173. p. 79. ISSN 0006-4971

Wassmann, Barbara and Pfeifer, Heike and Goekbuget, Nicola and Beelen, Dietrich W. and Beck, Joachim and Stelljes, Matthias and Bornhaeuser, Martin and Reichle, Albrecht and Perz, Jolanta and Haas, Rainer and Ganser, Arnold and Schmid, Mathias and Kanz, Lothar and Lenz, Georg and Kaufmann, Martin and Binckebanck, Anja and Brueck, Patrick and Reutzel, Regina and Gschaidmeier, Harald and Schwartz, Stefan and Hoelzer, Dieter and Ottmann, Oliver G. (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). BLOOD, 108 (5). pp. 1469-1477. ISSN 0006-4971, 1528-0020

Other

Ottmann, Oliver G. and Pfeifer, Heike and Cayuela, Jean-Michel and Spiekermann, Karsten and Jung, Wolfram and Beck, Joachim and Raffoux, Emmanuel and Turlure, Pascal and Himberlin, Chantal and Huguet, Francoise and Viardot, Andreas and Wendelin, Knut and Reichle, Albrecht and Maury, Sebastien and Sanhes, Laurence and Isnard, Francoise and Cahn, Jean-Yves and Lepretre, Stephane and Chevallier, Patrice and Escoffre-Barbe, Martine and Ribera, Josep-Maria and Hoelzer, Dieter and Goekbuget, Nicola and Dombret, Herve and Rousselot, Philippe (2018) Nilotinib (Tasigna (R)) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02). AMER SOC HEMATOLOGY, WASHINGTON.

Ottmann, Oliver G. and Pfeifer, Heike and Cayuela, Jean-Michel and Spiekermann, Karsten and Beck, Joachim and Jung, Wolfram E. and Viardot, Andreas and Kerstin, Schaefer-Eckart and Reichle, Albrecht and Maury, Sebastien and Schmitz, Norbert and Heidenreich, Daniela and Panse, Jens and Junghanss, Christian and Raffoux, Emmanuel and Suarez, Felipe and Guillerm, Gaeelle and Alexis, Magda and Lissandre, Severine and Huguet, Francoise and Isnard, Francoise and Lepretre, Stephane and Escoffre-Barbe, Martine and Ribera, Josep-Maria and Goekbuget, Nicola and Dombret, Herve and Hoelzer, Dieter and Rousselot, Philippe (2014) Nilotinib (Tasigna (R)) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Chromosome/BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL): A Trial of the European Working Group for Adult ALL (EWALL-PH-02). AMER SOC HEMATOLOGY, WASHINGTON.